Masimo Corporation Market Share Analysis
GlobalData’s new report, “Masimo Corporation Market Share Analysis” provides in-depth information on Masimo Corporation’s market position in the respiratory measurement devices market. The report also provides data and information on the overall competitive landscape within the respiratory measurement devices market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
- Global company shares (in Revenues) information for the respiratory measurement devices market.
- Masimo Corporation’s company shares (in Revenues) information for all the key countries the company has presence in -Brazil, Italy, Spain, United Kingdom, Germany, France, China, Japan, India, Australia, United States and Canada.
- Masimo Corporation’s company shares (in Revenues) information for the respiratory measurement devices market.
- All the key data-points are for 2011 and cover all the key regions -Europe, Asia-Pacific, North America, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.
Reasons to buy
- Develop sales and marketing strategies by identifying who-stands-where in the markets, Masimo Corporation’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Masimo Corporation’s market positions.
Masimo Corporation Market Share Analysis
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Anesthesia and Respiratory Devices 8
4 Company Snapshot 9
4.1 Key Facts 9
4.2 Company Overview 9
4.3 Financial Performance 9
4.4 SWOT Snapshot 9
4.5 Business Overview 10
4.6 Major Products and Services 11
5 History 13
6 SWOT Analysis 17
6.1 Overview 17
6.2 Masimo Corporation Strengths 17
6.3 Masimo Corporation Weaknesses 18
6.4 Masimo Corporation Opportunities 19
6.5 Masimo Corporation Threats 20
7 Competitors 21
8 Competitive Landscape 22
8.1 Anesthesia and Respiratory Devices (Respiratory Measurement Device), Global, Market Share (%), 2011 22
8.2 Masimo Corporation., Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Region, Market Share (2011) 24
8.3 Masimo Corporation, Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Country, Market Share (2011) 26
9 Key Employees 28
10 Key Employee Biographies 29
11 Company Statement 30
12 Locations And Subsidiaries 33
12.1 Head Office 33
12.2 Other Locations & Subsidiaries 33
13 Financial Deals Landscape 36
13.1 Masimo Corporation, Deals Volume Summary, 2006 to YTD 2012 36
14 Masimo Corporation Detailed Deal Summary 38
14.1 Asset Purchase 38
14.2 Partnerships 39
14.3 Equity Offering 60
14.4 Acquisition 62
15 Recent Developments 66
15.1 Strategy And Business Planning 66
15.2 Financial Announcements 68
15.3 Research And Development 84
15.4 Corporate Communications 88
15.5 Legal and Regulatory 91
15.6 Product News 94
15.7 Product Approvals 164
15.8 Clinical Trials 169
15.9 Other Significant Developments 192
16 Appendix 207
16.1 Research Methodology 208
16.2 Secondary Research 208
16.3 Primary Research 209
16.4 Models 209
16.5 Forecasts 209
16.6 Expert Panels 210
16.7 GlobalData Consulting 210
16.8 Currency Conversion 211
16.9 Contact Us 212
16.10 Disclaimer 212
1.1 List of Tables
Table 1: Masimo Corporation, Key Facts, 2011 18
Table 2: Masimo Corporation, SWOT Analysis, 2011 26
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 32
Table 4: Masimo Corporation., Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Region, Revenue ($m) and Market Share (%), 2011 34
Table 5: Masimo Corporation, Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Country, Revenue ($m) and Market Share (%), 2011 36
Table 6: Masimo Corporation, Key Employees 37
Table 7: Masimo Corporation, Other Locations 42
Table 8: Masimo Corporation, Subsidiaries 43
Table 9: Masimo Corporation, Deals Volume Summary, 2006 to YTD 2012 45
Table 10: Masimo Corporation, Deals Summary, 2006 to YTD 2012 46
Table 11: SEDLine Acquires SEDLine Brain Function Monitoring Business From Hospira 47
Table 12: Biolight Meditech Enters Into Licensing Agreement With Masimo 48
Table 13: Masimo Signs Licensing Agreement With Royal Fornia Electronic Device 49
Table 14: Fukuda Denshi Enters Into An Agreement With Masimo 50
Table 15: Masimo Enters Into Licensing Agreement With CareFusion 51
Table 16: Masimo Enters Into Licensing Agreement With GS Electro Medical Equipment 52
Table 17: Masimo Enters Into Licensing Agreement With Nihon Kohden 53
Table 18: Masimo Enters Into Licensing Agreement With ZOLL Medical 54
Table 19: Masimo Enters Into Licensing Agreement With Fukuda Denshi 55
Table 20: Zondan Enters Into Technology Integration Agreement With Masimo 56
Table 21: GE Healthcare Enters Into Technology Integration Agreement With Masimo 57
Table 22: Welch Allyn Enters Into Strategic Partnership With Masimo 58
Table 23: Masimo Enters Into Partnership Agreement With Royal Philips 59
Table 24: Newtech Enters Into An Agreement With Masimo 60
Table 25: Welch Allyn Enters Into Strategic Technology Integration Agreement With Masimo 61
Table 26: Masimo Enters Into Distribution Agreement With Oridion Systems 62
Table 27: Masimo Enters Into An Agreement With Oridion Systems 63
Table 28: Masimo Enters Into An Agreement With Schiller 64
Table 29: Welch Allyn Enters Into An Agreement With Masimo 65
Table 30: Atom Medical Enters Into An Agreement With Masimo 66
Table 31: Drager Medical Enters Into An Agreement With Masimo 67
Table 32: Respironics Enters Into An Agreement With Masimo 68
Table 33: Masimo Completes IPO Of $55.89 Million 69
Table 34: Masimo Acquires Phasein, Multigas Analyzers Maker, For $30 Million 71
Table 35: Masimo Completes Acquisition Of SEDLine 73
Table 36: SEDLine Receives Investment Of $3.5 Million From Masimo 74
Table 37: USD to Local Currency, Average Exchange Rate, 2011 220
1.2 List of Figures
Figure 1: Anesthesia and Respiratory Devices (Respiratory Measurement Device), Global, Market Share (%), 2011 31
Figure 2: Masimo Corporation., Anesthesia and Respiratory Devices), by Region, Market Share (%), 2011 33
Figure 3: Masimo Corporation., Anesthesia and Respiratory Devices), by Country, Market Share (%), 2011 35
Figure 4: Masimo Corporation, Deals Volume Summary, 2006 to YTD 2012 45
- Future of the Global Animal Feed Additives Market
The animal feed additives industry has witnessed steady growth in the last couple of years with increase in global meat consumption and rise in awareness among consumers about meat quality and safety. Feed additives are food supplement for farm animals that are unable get the required nutrients from regular feed. In 2011, the global market [...]
- Bright Future Predicted for the Fruit Wine Market
The fruit wine industry is witnessing a boom in recent years with increase in consumers’ interest. Earlier, fruit wines were considered to be a poor man’s alternative to conventional grape wines. Wine connoisseurs and purist did not consider fruit wine to be a wine at all and turned up their nose at its mention. However, [...]
- Future of the Ice Cream Market in the United States
In 2011, around 1.53 billion gallons of ice cream and related frozen desserts were produced in US. In 2010, the ice cream industry in US generated total revenue of $10 billion. During that period take-away home ice cream sales represented the largest segment in the market, generating revenue worth $6.8 billion which was 67.7% of [...]
- Global Micro Irrigation System Market Driven by Awareness about Water Conservation
The market for micro irrigation system has been growing at a steady pace and it is one of the fastest-growing segments of the agriculture industry. Micro irrigation is an irrigation method that allows water to drip down slowly to the roots of plants typically through a network of pipes, emitters, valves and tubing. With rise [...]
- Importance of Travel and Tourism Industry in Sri Lanka
Sri Lanka has been attracting tourists and foreign investors ever since the country gained its independence in 1948. Sri Lanka’s tourism has been growing steadily since the time the civil war ended in 2009. This has resulted in an exponential increase in the number of tourist visiting the country. The Sri Lankan government has also [...]
- Rapid Growth in the Opioid-Induced Constipation Market is Expected from 2012 to 2017
GlobalData estimates the 2012 sales for opioid-induced constipation (OIC) to be approximately $144.42m across the six major pharmaceutical markets covered in this forecast: the US, France, Germany, Italy, Spain, and the UK. The EU contributed the majority of these sales, …
- Greek Pharmaceutical Market to Show Modest Growth Despite Unstable Economy
The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek pharmaceutical market, which will increase from approximately $7.8 billion in 2013 to $8.2 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 0.6%, …
- Indian Pharmaceutical Market to Reach $56 billion in 2020
Driven by the country’s growing economy and population income, the Indian pharmaceutical market will increase significantly from approximately $21 billion in 2013 to $56 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 15%, forecasts research and consulting …
- Nonalcoholic Steatohepatitis Market to Grow Substantially by 2017
The growing global rate of obesity and diabetes will significantly boost the nonalcoholic steatohepatitis (NASH) market from $233 million in 2012 to $863 million by 2017, at a Compound Annual Growth Rate (CAGR) of 30%, forecasts research and consulting firm. …
- Border Disputes and Military Modernization Drive Chilean Defense Growth to 2018
Spurred by border disputes and military modernization initiatives, the Chilean defense expenditure – which is already one of the largest in South America – is forecast to grow from an estimated US$2.9 billion in 2014 at a CAGR of 8.69% …
2014 Research Report on Global and China Coronary Stent Industry
Published: 6-Mar-2014 Price: US $2200 Onwards Pages: 127
This is a professional and depth research report on Global and China Coronary Stent Industry. Firstly the report describes the background knowledge of Coronary Stent, including Coronary Stent Concepts Classification production process technical parameters; then statistics Global and China 18 Manufacturers Coronary Stent product 2009-2017 Capacity production cost price production value Gross margins and other relevant data, statistics these enterprises Coronary Stent products, customers, raw mate......
2014 Deep Research Report on Global and China Pacemaker Industry
Published: 6-Mar-2014 Price: US $2500 Onwards Pages: 301
This is a professional and depth research report on Global and China Pacemaker industry. This report has firstly introduced Pacemaker definition classification industry chain etc related information. Then introduced Pacemaker manufacturing technology and product specifications, And then summary statistics Global and China major Pacemaker manufacturers 2009-2017 Pacemaker capacity production supply demand shortage and Pacemaker selling price cost profit margin and production value, and also intro......
North American Healthcare Cloud Computing Market by Applications (EMR, PACS, RIS, RCM, APB), Deployment (Private, Public, Hybrid), Service (SAAS, IAAS), Pricing (Pay-As-You-Go, Spot) & End Users (Provider, Payers) – Forecast to 2018
Published: 5-Mar-2014 Price: US $4650 Onwards Pages: 353
The significance of cloud computing is expected to increase in the healthcare industry. The healthcare industry is facing increasing pressure to lower the costs associated with providing healthcare; adopt new systems that support electronic medical records (EMR); and share data in a quick and secure manner with other healthcare providers and government agencies. The need to reduce costs in the healthcare industry ecosystem is a key factor that is increasing the adoption of cloud computing. Moreo......
Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) – Trends & Forecast to 2018
Published: 5-Mar-2014 Price: US $4650 Onwards Pages: 195
Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries. It finds extensive applications in the biopharmaceutical industry as biopharmaceutical products and their intermediates are susceptible to degradation due to heat and chemical treatment, and so are difficult to separate using other techniques. Membrane filtration has been used in pharmaceutical industry since 1935 and it is presently one of the most widely adopted separation techniques i......
2014 Deep Research Report on Global And China Pectinase Industry
Published: 5-Mar-2014 Price: US $2200 Onwards Pages: 150
This is a professional and depth research report on Global and China Pectinase industry. The report firstly introduced Pectinase basic information included Pectinase definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Pectinase industry policy and plan, Pectinase product specification, manufacturing process, cost structure etc. then statistics Gl......
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2014
Published: 5-Mar-2014 Price: US $1295 Onwards Pages: 102
BMI View: The pharmaceutical manufacturing sector will remain an economic mainstay for Puerto Rico.
The local government is focused on defending the commonwealth nation's position as a global
pharmaceutical production hub by offering incentives for the expansion of existing manufacturing plants
and pursuing new opportunities in contract manufacturing operations as well as generic and biologic drug
production. However, it will be difficult for the island to return to its former pharmaceutical man......
Romania Pharmaceuticals and Healthcare Report Q2 2014
Published: 5-Mar-2014 Price: US $1295 Onwards Pages: 115
BMI View: Romania's pharmaceutical market will post moderate growth over the short term due to
continued focus on price controls, limited reimbursement of pharmaceuticals and stubbornly high
unemployment levels. Unemployment levels and the state of Romania's economy directly impact revenues
for the state insurer; while the country's economic picture in early 2014 is improving, the benefits will not
be felt until the medium term. These issues continue to weigh down our assessment of the Romanian
United States Pharmaceuticals and Healthcare Report Q2 2014
Published: 5-Mar-2014 Price: US $1295 Onwards Pages: 120
BMI View: Pharmaceutical companies are facing far greater opportunities and challenges than
the Affordable Care Act (ACA). Healthcare reform in the US could have sought significant monetary
contributions from drugmakers, but this did not materialise in a meaningful sense, primarily due to industry
cooperation when the legislation was being drafted. Of greater near-term concern to pharmaceutical
companies is the shifting pricing and reimbursement landscape globally.
Headline Expenditure Projectio......
Canada Pharmaceuticals and Healthcare Report Q2 2014
Published: 5-Mar-2014 Price: US $1295 Onwards Pages: 116
BMI View: On the back of more promising a macroeconomic outlook in 2014, we believe the Canadian
pharmaceutical and healthcare market will be more attractive to pharmaceutical companies. Although
drugmakers will continue to face generic competition and drug pricing pressure in the country, improving
healthcare coverage and broader drug reimbursement lists will increase patients' access to medicines and
provide revenue-generating opportunities for drugmakers.
Headline Expenditure Projections
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details - firstname.lastname@example.org
/ +1 888 391 5441 )
- Ad Hoc
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs